Ceftolozane-tazobactam versus levofloxacin in urinary tract infection Reply

被引：3
|
作者：
Wagenlehner, Florian M. [1 ]
Umeh, Obiamiwe [2 ]
Darouiche, Rabih O. [3 ,4 ]
机构：
[1] Univ Giessen, Clin Urol Pediat Urol & Androl, D-35392 Giessen, Germany
[2] Merck Sharp & Dohme Cubist Pharmaceut, Lexington, MA USA
[3] Michael E DeBakey VA Med Ctr, Houston, TX USA
[4] Baylor Coll Med, Houston, TX 77030 USA
来源：
LANCET | 2015年 / 386卷 / 10000期
关键词：
D O I：
10.1016/S0140-6736(15)00263-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1242 / 1242
页数：1
相关论文
共 50 条
  • [1] Ceftolozane-tazobactam versus levofloxacin in urinary tract infection
    Popa, Ciprian
    Mircheva, Miryana
    Kraemer, Bernhard K.
    Berghofen, Andrea
    Krueger, Bernd
    LANCET, 2015, 386 (10000): : 1241 - 1242
  • [2] Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infections
    Giancola, Stephanie E.
    Mahoney, Monica V.
    Bias, Tiffany E.
    Hirsch, Elizabeth B.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 787 - 797
  • [3] Ceftolozane-tazobactam in nosocomial pneumonia
    Javier Candel, Francisco
    Gonzalez del Castillo, Juan
    Julian Jimenez, Agustin
    Matesanz, Mayra
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 35 - 39
  • [4] Ceftolozane/tazobactam vs meropenem in neonates and children with complicated urinary tract infection
    Dhull, Rachita Singh
    INDIAN PEDIATRICS, 2023, 60 (04) : 326 - 326
  • [5] Physicochemical Compatibility of Ceftolozane-Tazobactam with Parenteral Nutrition
    De Pourcq, Jan Thomas
    Riera, Adria
    Gras, Laura
    Garin, Noe
    Busquets, Maria Antonia
    Cardenete, Joana
    Cardona, Daniel
    Riera, Pau
    PHARMACEUTICALS, 2024, 17 (07)
  • [6] Ceftolozane-tazobactam: A new-generation cephalosporin
    Cluck, David
    Lewis, Paul
    Stayer, Brooke
    Spivey, Justin
    Moorman, Jonathan
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (24) : 2135 - 2146
  • [7] CEFTOLOZANE-TAZOBACTAM DOSING IN PATIENTS WITH CYSTIC FIBROSIS
    Rusnak, A.
    Sakon, C.
    Wrin, J.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S248 - S248
  • [8] Patterns of use of ceftolozane-tazobactam in a tertiary hospital
    Gras Martin, L.
    Lopez Vinardell, L.
    de Gamarra Martinez, E. Fernandez
    Lopez-Contreras Gonzalez, J.
    Conejo Marin, I.
    Mas Malagarriga, N.
    Mangues Bafalluy, M. A.
    Garin Escriva, N.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 279 - 280
  • [9] CEFTOLOZANE-TAZOBACTAM ACTIVITY VERSUS RESISTANT PSEUDOMONAS AERUGINOSA FROM PNEUMONIA IN THE US
    Shortridge, Dee
    Streit, Jennifer
    DeRyke, Andrew
    Flamm, Robert
    CRITICAL CARE MEDICINE, 2020, 48
  • [10] Ceftolozane-tazobactam: When, how and why using it?
    Lopez Montesinos, Inmaculada
    Montero, Milagro
    Sorli, Luisa
    Horcajada, Juan P.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 : 35 - 37
12345